Human Molecular Genetics Advance Access published online on January 20, 2004
Human Molecular Genetics, doi:10.1093/hmg/ddh063
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medical Microbiology and Immunology, Rowe Program in Human Genetics, School of Medicine, 1 Shields Ave., University of California, Davis, CA, 95616, USA
* To whom correspondence should be addressed. E-mail: jmlasalle{at}ucdavis.edu.
Rett syndrome (RTT) is a neurodevelopmental disorder caused by mutations in MECP2, encoding methyl-CpG-binding protein 2 (MeCP2). Although MECP2 is ubiquitously transcribed, MeCP2 expression is developmentally regulated and heterogeneous in neuronal subpopulations, defined as MeCP2lo and MeCP2hi. To test the hypothesis that pathways affecting MeCP2 expression changes may be defective in RTT, autism, and other neurodevelopmental disorders without MECP2 mutations, a high throughput quantitation of MeCP2 expression was performed on a tissue microarray containing frontal cortex samples from 28 different patients with neurodevelopmental disorders and age-matched controls. Combined quantitative analyses of MeCP2 protein and alternatively polyadenylated transcript levels were performed by laser scanning cytometry and tested for significant differences from age-matched controls. Normal cerebral samples showed an increase in total MeCP2 expression and the percentage of MeCP2hi cells with age that could be explained by increased MECP2 transcription within the MeCP2hi population. A significant decrease in the relative usage of the long transcript in the MeCP2lo population was observed in postnatal compared to fetal brain, but alternate polyadenylation did not correlate with MeCP2 expression changes at the single cell level. Brain samples from several related neurodevelopmental disorders, including autism, pervasive developmental disorder, Prader-Willi and Angelman syndromes showed significant differences in MeCP2 expression from age-matched controls by apparently different transcriptional and posttranscriptional mechanisms. These results suggest that multiple pathways regulate the complex developmental expression of MeCP2 and are defective in autism-spectrum disorders in addition to RTT.
Article
Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Kerr, M. Alvarez-Saavedra, M. A. Saez, A. Saona, and J. I. Young Defective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice Hum. Mol. Genet., June 15, 2008; 17(12): 1707 - 1717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Samaco, J. D. Fryer, J. Ren, S. Fyffe, H.-T. Chao, Y. Sun, J. J. Greer, H. Y. Zoghbi, and J. L. Neul A partial loss of function allele of Methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome Hum. Mol. Genet., June 15, 2008; 17(12): 1718 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hogart, R. P. Nagarajan, K. A. Patzel, D. H. Yasui, and J. M. LaSalle 15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders Hum. Mol. Genet., March 15, 2007; 16(6): 691 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Petel-Galil, B Ben-Zeev, I Greenbaum, M Vecsler, B Goldman, H Lohi, B A Minassian, and E Gak Comprehensive diagnosis of Rett's syndrome relying on genetic, epigenetic and expression evidence of deficiency of the methyl-CpG-binding protein 2 gene: study of a cohort of Israeli patients J. Med. Genet., December 1, 2006; 43(12): e56 - e56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Friez, J. R. Jones, K. Clarkson, H. Lubs, D. Abuelo, J.-A. B. Bier, S. Pai, R. Simensen, C. Williams, P. F. Giampietro, et al. Recurrent Infections, Hypotonia, and Mental Retardation Caused by Duplication of MECP2 and Adjacent Region in Xq28 Pediatrics, December 1, 2006; 118(6): e1687 - e1695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jordan and U. Francke Ube3a expression is not altered in Mecp2 mutant mice Hum. Mol. Genet., July 15, 2006; 15(14): 2210 - 2215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Peddada, D. H. Yasui, and J. M. LaSalle Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome Hum. Mol. Genet., June 15, 2006; 15(12): 2003 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Moretti, J. M. Levenson, F. Battaglia, R. Atkinson, R. Teague, B. Antalffy, D. Armstrong, O. Arancio, J. D. Sweatt, and H. Y. Zoghbi Learning and Memory and Synaptic Plasticity Are Impaired in a Mouse Model of Rett Syndrome J. Neurosci., January 4, 2006; 26(1): 319 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Y. Zoghbi MeCP2 Dysfunction in Humans and Mice J Child Neurol, September 1, 2005; 20(9): 736 - 740. [Abstract] [PDF]
|
|
|
|
|
|
H. Y. Zoghbi MeCP2 Dysfunction in Humans and Mice J Child Neurol, August 1, 2005; 20(8): 736 - 740. [Abstract] [PDF]
|
|
|
|
|
|
I. M. Caballero and B. Hendrich MeCP2 in neurons: closing in on the causes of Rett syndrome Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R19 - R26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. N. Thatcher, S. Peddada, D. H. Yasui, and J. M. LaSalle Homologous pairing of 15q11-13 imprinted domains in brain is developmentally regulated but deficient in Rett and autism samples Hum. Mol. Genet., March 15, 2005; 14(6): 785 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Samaco, A. Hogart, and J. M. LaSalle Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3 Hum. Mol. Genet., February 15, 2005; 14(4): 483 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Moretti, J. A. Bouwknecht, R. Teague, R. Paylor, and H. Y. Zoghbi Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome Hum. Mol. Genet., January 15, 2005; 14(2): 205 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Collins, J. M. Levenson, A. P. Vilaythong, R. Richman, D. L. Armstrong, J. L. Noebels, J. David Sweatt, and H. Y. Zoghbi Mild overexpression of MeCP2 causes a progressive neurological disorder in mice Hum. Mol. Genet., November 1, 2004; 13(21): 2679 - 2689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Braunschweig, T. Simcox, R. C. Samaco, and J. M. LaSalle X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain Hum. Mol. Genet., June 15, 2004; 13(12): 1275 - 1286. [Abstract] [Full Text] [PDF]
|
|